Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

PURPOSE: Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) is a malignant neoplasm of predominantly salivary gland origin for which effective therapies are lacking. We conducted a phase II trial evaluating the multitargeted tyrosine kinase inhibitor lenvatinib in patients with R/M ACC. PATI...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Tchekmedyian, Vatche, Sherman, Eric J., Dunn, Lara, Tran, Crystal, Baxi, Shrujal, Katabi, Nora, Antonescu, Cristina R., Ostrovnaya, Irina, Haque, Sofia S., Pfister, David G., Ho, Alan L.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2019
主題:
RAPID COMMUNICATIONS
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6599407/
https://ncbi.nlm.nih.gov/pubmed/30939095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01859
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料